EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development of Highly Potent Noncovalent Inhibitors of SARS-CoV-2 3CLpro

Ningke Hou iD, Lei Shuai, Lijing Zhang, Xuping Xie, Kaiming Tang, Yunkai Zhu, Yin Yu, Wenyi Zhang, Qiaozhu Tan, Gongxun Zhong, Zhiyuan Wen, Chong Wang und 19 weitere

ACS Central Science · 22.02.2023 · 9 (2) · 217-227

DOI: 10.1021/acscentsci.2c01359 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Central Science, online erschienen am 25.01.2023. Verfasst von Ningke Hou und 30 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Structural Biology of Zhejiang Province, School of Life Sciences, Westlake University; Center for Infectious Disease Research, West…. Die Arbeit wurde bisher 108-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Ministry of Science and Technology of the People's Republic of China, National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Key Laboratory of Structural Biology of Zhejiang Province, School of Life Sciences, Westlake University; Center for Infectious Disease Research, Westlake Laboratory of Life Sciences and Biomedicine; Institute of Biology…
  • State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, No.678 Haping Road, Xiangfang District, Harbin 150069, China.
  • National High Containment Laboratory for Animal Diseases Control and Prevention, Harbin 150069, China.
  • Key Laboratory of Structural Biology of Zhejiang Province, School of Life Sciences, Center for Infectious Disease Research, Westlake Laboratory of Life Sciences and Biomedicine, Institute of Biology, Westlake Institute…
  • Zhejiang University, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, China.
  • Department of Biochemistry and Molecular Biology, Institute for Human Infection and Immunity, University of Texas Medical Branch, Galveston, Texas 77555, United States.

ORCID-Profile: Ningke Hou, Craig Schindewolf, Wenji Su, Shuofeng Yuan, Jing Huang, Qi Hu

Förderung

  • NIAID NIH HHS
  • Ministry of Science and Technology of the People's Republic of China
  • National Natural Science Foundation of China
  • Natural Science Foundation of Zhejiang Province
  • Westlake Education Foundation
  • Tencent Foundation

Zitieren

APA

Hou, N., Shuai, L., Zhang, L., Xie, X., Tang, K., Zhu, Y., Yu, Y., Zhang, W., Tan, Q., Zhong, G., Wen, Z., Wang, C., He, X., Huo, H., Gao, H., Xu, Y., Xue, J., Peng, C., Zou, J., …, & Hu, Q. (2023). Development of Highly Potent Noncovalent Inhibitors of SARS-CoV-2 3CLpro. ACS Central Science, 9(2), 217-227. https://doi.org/10.1021/acscentsci.2c01359

Vancouver

Hou N, Shuai L, Zhang L, Xie X, Tang K, Zhu Y, et al. Development of Highly Potent Noncovalent Inhibitors of SARS-CoV-2 3CLpro. ACS Central Science. 2023;9(2):217-227. doi:10.1021/acscentsci.2c01359

BibTeX
@article{Hou2023,
  author = {Hou, Ningke and Shuai, Lei and Zhang, Lijing and Xie, Xuping and Tang, Kaiming and Zhu, Yunkai and Yu, Yin and Zhang, Wenyi and Tan, Qiaozhu and Zhong, Gongxun and Wen, Zhiyuan and Wang, Chong and He, Xijun and Huo, Hong and Gao, Haishan and Xu, You and Xue, Jing and Peng, Chen and Zou, Jing and Schindewolf, Craig and Menachery, Vineet and Su, Wenji and Yuan, Youlang and Shen, Zuyuan and Zhang, Rong and Yuan, Shuofeng and Yu, Hongtao and Shi, Pei-Yong and Bu, Zhigao and Huang, Jing and Hu, Qi},
  title = {Development of Highly Potent Noncovalent Inhibitors of SARS-CoV-2 3CLpro},
  journal = {ACS Central Science},
  year = {2023},
  volume = {9},
  number = {2},
  pages = {217--227},
  doi = {10.1021/acscentsci.2c01359}
}
Kostenlos starten →